Illumina Inc. (ILMN)

357.74
3.82 1.06
NASDAQ : Health Technology
Prev Close 361.56
Open 361.60
Day Low/High 357.61 / 363.28
52 Wk Low/High 268.62 / 372.61
Volume 665.79K
Avg Volume 904.90K
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 52.71B
EPS 5.60
P/E Ratio 62.69
Div & Yield N.A. (N.A)

Latest News

VeriSeq NIPT Solution V2 (Photo: Business Wire)

VeriSeq NIPT Solution V2 (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of VeriSeq ™ NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT).

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Illumina Files Patent Infringement Suit Against BGI In Denmark

Illumina Files Patent Infringement Suit Against BGI In Denmark

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group's subsidiaries, BGI Europe A/S.

Population Health Study Goes Statewide As University Medical Center Of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

Population Health Study Goes Statewide As University Medical Center Of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Helix Expands Focus To Population Health Solutions And Appoints Illumina Veteran Marc Stapley As CEO

Helix Expands Focus To Population Health Solutions And Appoints Illumina Veteran Marc Stapley As CEO

SAN CARLOS, Calif., April 25, 2019 /PRNewswire/ -- Helix today announced it is broadening its market focus to include health systems, payers and researchers who are interested in sequencing large population cohorts.

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2019

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2019

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2019.

The New #37 Most Shorted Nasdaq 100 Component: Illumina

The New #37 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina To Announce First Quarter 2019 Financial Results On Thursday, April 25, 2019

Illumina To Announce First Quarter 2019 Financial Results On Thursday, April 25, 2019

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2019 following the close of market on Thursday, April 25, 2019.

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'

Illumina Files Patent Infringement Suit Against BGI In Germany

Illumina Files Patent Infringement Suit Against BGI In Germany

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group's subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany.

The Mysteries Hidden Within Ancient DNA May Harness The Answers To Today's Mental Health Epidemic.

The Mysteries Hidden Within Ancient DNA May Harness The Answers To Today's Mental Health Epidemic.

Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens.

Illumina Moves Up In Analyst Rankings, Passing Harris

Illumina Moves Up In Analyst Rankings, Passing Harris

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #46 spot from Harris Corp. , according to ETF Channel.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 02/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

5 Attractive Ways to Invest in Oncology

5 Attractive Ways to Invest in Oncology

Experts offer their top stock ideas in oncology detection and treatment.

Hot Cancer Detection Stock Still Has Room to Run

Hot Cancer Detection Stock Still Has Room to Run

Guardant's liquid biopsy lets oncologists see all of the genomic information of a patient's tumor with a simple blood test. The alternative is a tissue biopsy which can be expensive and risky.

Illumina Could Rally to Break Its Downtrend

Illumina Could Rally to Break Its Downtrend

Here's how we would play ILMN stock right now.

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti Holdings, Cronos Group, Manitowoc, Crispr Therapeutics, Palo Alto Networks, Etsy and more.

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

Cramer's got the winners, the losers and the wild cards in the China trade brouhaha.

Health Care Is About to Improve Dramatically; Here's How to Play it

Health Care Is About to Improve Dramatically; Here's How to Play it

Governments and physicians around the globe struggle to deliver high quality healthcare at a reasonable price. But fresh medical technology innovators are coming, and there's one in particular worth looking at.

Sue Siegel (Photo: Business Wire)

Sue Siegel (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company's Board of Directors effective February 5, 2019.

Illumina Sinks on Fourth-Quarter Earnings Miss

Illumina Sinks on Fourth-Quarter Earnings Miss

Shares of Illumina fall after the genetic testing tools company misses Wall Street's fourth-quarter earnings expectations.

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2018

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2018.

Illumina To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On Tuesday, January 29, 2019

Illumina To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On Tuesday, January 29, 2019

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2018 following the close of market on Tuesday, January 29, 2019.

Illumina Becomes #44 Most Shorted Nasdaq 100 Component, Replacing American Airlines Group

Illumina Becomes #44 Most Shorted Nasdaq 100 Component, Replacing American Airlines Group

The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina Moves Up In Market Cap Rank, Passing Raytheon

Illumina Moves Up In Market Cap Rank, Passing Raytheon

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Illumina Inc has taken over the #115 spot from Raytheon Co. , according to The Online Investor.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

TheStreet Quant Rating: B (Buy)